Seabelife

Developer of small-molecule drugs that simultaneously inhibit necroptosis and ferroptosis

placeRoscoff, Brittany, France calendar_todayFounded 2019 groups8 employees language seabelife.com

Social engagement

Social engagement: 2.8K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Bpifrance, Breizh Angels, iXLife Capital.

Investor typeCountShare
Venture capital218%
Angel & family office436%
Bank & private debt19%
Other / undisclosed436%

Recent activity

24 Jun 2026
Event
HealthTech Accelerations Summit
18 May 2026
Event
Cell Death: Mechanisms, Pathways and Therapeutic Innovations
7 May 2026
Event
Cell Death: Mechanisms, Pathways and Therapeutic Innovations
Coming soon